Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Netcare Limited (NTC.JO)
Sandton, ZA
Netcare Limited, an investment holding company with its headquarters in Sandton, South Africa, is a prominent operator of private hospitals across the country. The organization's activities are divided into two main segments: Hospital and Emergency Services, and Primary Care. The Hospital and Emergency Services division oversees the company's network of private acute care hospitals, day clinics, and pharmaceutical operations. This segment also provides a range of non-acute services, including emergency medical response, the management of private mental health clinics, and specialized cancer care. Additionally, it offers various healthcare products and vouchers. The Primary Care segment is focused on delivering general healthcare services, employee health and wellness programs, and administrative support for medical and dental practices. Netcare boasts an extensive healthcare infrastructure throughout South Africa, which includes 51 private hospitals, two public-private partnership hospitals, and a total capacity of 10,605 registered beds. Its specialized facilities encompass 10 cancer care centers, 422 operating theaters, and 63 renal dialysis units featuring 860 stations. The primary care network consists of 95 centers and 15 Medicross day theaters, alongside 79 Netcare 911 emergency sites. The company further operates 7 training campuses and 12 mental health and psychiatric clinics, providing 841 beds. Netcare Limited was founded in 1996.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +7.14% | +11.66% | +5.14% | +7.46% | +18.11% | +13.71% | +25.09% | +26.32% | +20.48% | -44.44% | -78.05% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+4.5% Q1'26: +10.4% (vs Q1'24)
-
EPS growth Medical - Care Facilities: +19.2%+22.0% ★ Q1'26: -27.8% (vs Q1'24)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+8.0% ★ Q1'26: +3.5% (vs Q1'24)
-
EBIT margin Medical - Care Facilities: +11.3%+14.2% ★ Q1'26: +11.1% (vs Q1'24)
-
ROIC Medical - Care Facilities: +6.8%+12.2% ★ Q1'26: +18.7% (vs Q1'24)
-
Share dilution Medical - Care Facilities: +0.0%-4.0% ★ Q1'26: -7.9% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.55× Q1'26: 1.56× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Sep 2015 actual |
Sep 2016 actual |
Sep 2017 actual |
Sep 2018 actual |
Sep 2019 actual |
Sep 2020 actual |
Sep 2021 actual |
Sep 2022 actual |
Sep 2023 actual |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 5 Rev. Ana. 1 EPS Ana. |
Sep 2027 5 Rev. Ana. 3 EPS Ana. |
Sep 2028 4 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
33.71B
est: 34.04B (-1.0%)
|
37.73B
est: 37.54B (+0.5%)
|
19.11B
est: 34.73B (-45.0%)
|
20.72B
est: 21.46B (-3.5%)
|
21.59B
est: 21.76B (-0.8%)
|
18.84B
est: 19.19B (-1.8%)
|
21.20B
est: 20.91B (+1.4%)
|
21.64B
est: 22.21B (-2.6%)
|
23.70B
est: 24.20B (-2.1%)
|
25.20B
est: 25.05B (+0.6%)
|
26.34B
est: 26.58B (-0.9%)
|
27.54B
27.50B – 27.63B
+3.6% YoY
|
28.73B
28.58B – 29.00B
+4.3% YoY
|
30.02B
29.99B – 30.05B
+4.5% YoY
|
| EBITDA |
3.97B
est: 5.87B (-32.4%)
|
3.78B
est: 6.47B (-41.7%)
|
4.49B
est: 5.99B (-25.1%)
|
2.89B
est: 3.70B (-22.0%)
|
4.63B
est: 3.75B (+23.4%)
|
2.86B
est: 3.31B (-13.5%)
|
3.18B
est: 3.61B (-11.9%)
|
3.54B
est: 3.83B (-7.7%)
|
4.08B
est: 4.17B (-2.2%)
|
4.63B
est: 4.32B (+7.0%)
|
5.09B
est: 4.58B (+11.1%)
|
4.75B
4.74B – 4.77B
+3.6% YoY
|
4.96B
4.93B – 5.00B
+4.3% YoY
|
5.18B
5.17B – 5.18B
+4.5% YoY
|
| EBIT |
3.97B
est: 4.05B (-2.0%)
|
2.54B
est: 4.46B (-43.2%)
|
3.93B
est: 4.13B (-4.8%)
|
2.24B
est: 2.55B (-12.4%)
|
3.96B
est: 2.59B (+53.0%)
|
1.71B
est: 2.28B (-25.1%)
|
2.02B
est: 2.49B (-18.8%)
|
2.36B
est: 2.64B (-10.6%)
|
2.81B
est: 2.88B (-2.4%)
|
3.29B
est: 2.98B (+10.5%)
|
3.74B
est: 3.16B (+18.4%)
|
3.28B
3.27B – 3.29B
+3.6% YoY
|
3.42B
3.40B – 3.45B
+4.3% YoY
|
3.57B
3.57B – 3.57B
+4.5% YoY
|
| Net Income |
2.46B
est: 2.33B (+5.7%)
|
1.72B
est: 2.38B (-27.8%)
|
4.71B
est: 2.07B (+127.9%)
|
1.13B
est: 2.03B (-44.0%)
|
2.45B
est: 2.03B (+20.8%)
|
446.00M
est: 875.15M (-49.0%)
|
769.00M
est: 840.20M (-8.5%)
|
1.01B
est: 1.04B (-3.0%)
|
1.26B
est: 1.22B (+2.8%)
|
1.50B
est: 1.45B (+3.5%)
|
1.74B
est: 1.66B (+5.3%)
|
1.86B
1.85B – 1.87B
+12.2% YoY
|
2.04B
1.96B – 2.13B
+9.9% YoY
|
2.42B
2.37B – 2.46B
+18.4% YoY
|
| SGA |
11.63B
est: 13.32B (-12.7%)
|
12.87B
est: 14.69B (-12.4%)
|
6.62B
est: 13.59B (-51.3%)
|
7.42B
est: 8.40B (-11.7%)
|
7.74B
est: 8.51B (-9.1%)
|
7.75B
est: 7.51B (+3.2%)
|
8.52B
est: 8.19B (+4.1%)
|
8.57B
est: 8.69B (-1.4%)
|
9.37B
est: 9.47B (-1.0%)
|
9.64B
est: 9.80B (-1.7%)
|
10.04B
est: 10.40B (-3.5%)
|
10.78B
10.76B – 10.81B
+3.6% YoY
|
11.24B
11.18B – 11.35B
+4.3% YoY
|
11.75B
11.74B – 11.76B
+4.5% YoY
|
| EPS |
1.79
est: 1.87 (-4.2%)
|
1.22
est: 1.91 (-36.2%)
|
3.46
est: 1.66 (+108.6%)
|
0.83
est: 1.63 (-49.0%)
|
1.77
est: 1.63 (+8.9%)
|
0.28
est: 0.70 (-60.1%)
|
0.55
est: 0.67 (-18.4%)
|
0.72
est: 0.84 (-14.0%)
|
0.96
est: 0.98 (-2.0%)
|
1.10
est: 1.16 (-5.2%)
|
1.35
est: 1.33 (+1.9%)
|
1.49
1.48 – 1.50
+12.3% YoY
|
1.66
1.57 – 1.71
+11.4% YoY
|
1.94
1.90 – 1.98
+17.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-25 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Sophus Capital Emerging Market Small Cap ETF EMSC | 0.66% | 293.0K | 0.85% |
| 2 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.40% | 175.1K | 0.54% |
| 3 | WisdomTree Emerging Markets Equity Income UCITS ETF DEMD.L | 0.21% | 551.5K | 0.46% |
| 4 | WisdomTree Emerging Markets Equity Income UCITS ETF - Acc DEMR.L | 0.21% | 551.5K | 0.46% |
| 5 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.20% | 3.55M | 0.58% |
| 6 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.16% | 187.9K | 0.42% |
| 7 | WisdomTree Emerging Markets High Dividend Fund DEM | 0.14% | 5.62M | 0.63% |
| 8 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.14% | 489.6K | 0.58% |
| 9 | iShares Ageing Population UCITS ETF AGED.L | 0.11% | 999.0K | 0.40% |
| 10 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.09% | 543.1K | 0.55% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Richard Harold Friedland BvSc Man | Group Chief Executive Officer & Executive Director | 16M | — |
| Keith N. Gibson | Group Chief Financial Officer & Executive Director | 10M | male |
| Craig Grindell | Managing Director of Netcare 911 | 6M | male |
| Erich Bock | Managing Director of Hospital Division | 6M | — |
| Teshlin Akaloo | Managing Director of Innovative Products | 5M | male |
| Sara Nayager | Managing Director of Primary Care | 3M | female |
| Travis Dewing | Chief Information Officer | — | male |
| Gershon Venkatasamy | Chief data & AI officer | — | — |
| Nceba Ndzwayiba | Group HR & Transformation Director | — | — |
| Charles Vikisi | Group Company Secretary & General Counsel | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NTC.JO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
